News
The end of production at one of pharmaceutical firm GlaxoSmithKline's (GSK) UK factories is a "sad day", a former worker has ...
Global Sepsis Treatment Market Report: Growth, Expansion, and Strategic Insights (2025–2033) The Global Sepsis Treat ...
After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...
A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...
Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...
Gen Z's preference for convenient formats like gummies and effervescent powders, coupled with rising health awareness, is ...
Neurofibromatosis Type 2 Market Insight, Epidemiology And Market Forecast - 2034The Neurofibromatosis Type 2 treatment market is experiencin ...
Tens of thousands of people protested in at least 27 of Kenya’s 47 counties last week, some of the biggest anti-government ...
It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results